View drug registration information details.
| Items | Registration information |
|---|
| ID | 2077 |
|---|
| No | 2077 |
|---|
| Brand Name | LOSART 50 |
|---|
| Ingredients | LOSARTAN POTASSIUM USP 50 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-PVC BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARD |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | HYPERTENSION : LOSART IS INDICATED FOR THE TREATMENT OF HYPERTENSION. HYPERTENTIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY : LOSART IS INDICATED TO REDUCE THE RISK OF STROKE IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TO OFF WHITE, ROUND, SEMI BI - CONVEX, FILM - COATED TABLETS ENGRAVED " ACME " ON ONE FACE AND A BREAKLINE ON THE OTHER FACE. |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | THE ACME LABORATORIES LTD. |
|---|
| Country | BANGLADESH |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 I 4218/17 |
|---|
| FDD Registration Date | 19-MAY-2023 |
|---|
| Expiry Date | 18-MAY-2026 |
|---|
Back to drug list
|
